Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Syneos Health, Inc.

Syneos Health, Inc. (SYNH) Stock Overview

Explore Syneos Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SYNH●NASDAQ
HealthcareMedical - Diagnostics & Research
$42.98
$0.010(0.02%)
U.S. Market opens in 13h 59m

Syneos Health, Inc. (SYNH)

Meyka AI Score

Z

Key Financials

Market Cap4.5B
P/E Ratio16.72
EPS (TTM)$0.70
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

SYNH Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Syneos Health, Inc. (NASDAQ: SYNH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Syneos Health, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SYNH on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Syneos Health, Inc.'s NASDAQ-traded stock include a P/E ratio of 16.72 and a market capitalization of 4.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SYNH on the NASDAQ.

Price Performance (NASDAQ: SYNH)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.30%
6-Month Change
13.55%
Year-to-Date (YTD) Change
18.30%
1-Year Change
-13.22%
3-Year Change
-23.14%
5-Year Change
-3.78%
All-Time (Max) Change
109.76%

Contact Information

https://www.syneoshealth.com
919 876 9300
1030 Sync Street, Morrisville, NC, 27560-5468

Company Facts

287,680 Employees
IPO DateNov 7, 2014
CountryUS

Frequently Asked Questions